Abstract
Introduction
Time-dependent therapeutic response exists in cell-based cardiac repair after myocardial infarction (MI) [1] . Results from clinical or experimental research have shown that the optimal time frame for bone marrow-derived cell therapy for MI might be day 5 to week 2 after the infarction [2] [3] [4] [8] . The work here attempts to verify the hypothesis and in vitro accesses the effects of the stiffness of infarcted myocardium on the specification of bone marrow-derived cells along endothelial progenitor lineage.
Materials and methods

Animal models
Male Balb/c mice were 6 weeks of age at the start of the experimental protocol. Mouse models of MI were prepared by the ligation of the left anterior descending artery as described previously [9] . Briefly, a thoracotomy was performed through the fourth left intercostal space, and the proximal left anterior descending artery was permanently ligated by a 8.0 silk suture. (NIH Pub. No. 86-23, revised 1996) [12] .
Control animals only underwent thoracotomy. All animal experiments were performed in accordance with the National Institutes of Health Guide for the Care and Use of Laboratory Animals
In vitro mimicry of myocardial stiffness and preparation of cell culture dishes
The variably compliant polyacrylamide gels were prepared according to a previously established protocol by Pelham and Wang [13] . Fig. 1A Fig. 1A, C, G Fig. 1A, D-G) .
The time-related changes in stiffness of infarcted myocardium might be closely associated with the pathological changes following MI. Hearts at hour 24 after MI had more significant inflammatory cells infiltration following massive myonecrosis, which could account for the phenomenon of myocardial stiffness decreasing to the lowest level at this time (Fig. 1C) . By day 7, the removal of the necrotic myocytes was paralleled by a reduction of inflammatory cells with the start of immature fibrosis scar formation. And the process completed by 28 days after MI. The fibrotic process might greatly contribute to the time-related increase in the stiffness of infarcted myocardium (Fig. 1D-F Fig. 2 ).
Cardiac function recovery after cell treatment
Compared with the M199 injection at respective time-points, cell treatment at hour 24, day 7 and day 14 after MI significantly improved LVEF, FS, left ventricular end-diastolic pressure (LVEDP) and Ϯdp/dt after the infarction (Fig. 3A1, B1; Fig. 4A1, C1, D1 (Fig. 3A2, B2; Fig. 4A2, D2) (Fig. 3C2 and D2 ). (Fig. 1G) , respectively. (Fig. 7) . When the culture condition was changed to 10 ng/ml VEGF, the stiffness of 42 and 15 kPa, corresponding to myocardium at days 7 to 14 and hour 1 after MI, respectively, showed significant benefits only in the number of double-positive cells per HPF (Fig. 8) (Fig. 9) (Fig. 10) (Fig. 11A) [16] [17] . These beneficial effects are in favour of broken heart repair and functional recovery [16] . In an animal experiment BMMNCs exhibit a more favourable survival pattern which translates into a more robust preservation of cardiac function compared to mesenchymal stem cells, skeletal myoblasts and fibroblasts [17] . Currently BMMNCs have become the most widely used cell populations in clinical practices [3, 18] . BMMNCs fate after transplantation contributed largely to cell efficacy. Neovascularization of ischemic cardiac may be sufficient to preserve tissue integrity or function and may thus be considered as a therapeutic goal [19] . Recently, Yoon et al. [20] demonstrated [21] [22] [23] [24] . As a [5, 30] . Integrin, as the main receptors that connect the cytoskeleton to the extracellular matrix, mediates cell focal adhesion to sense the mechanical force [30] and regulates signalling pathways [31] . Subsequently, actin cytoskeletons were assembled or disassembled under regulations of altering non-muscle myosin II expression [5] [32] . Even the same cytokines often have paradoxical effects or counteract each other [33] [34] Current observations contribute to understand the mechanism underlying the optimal timing of BMMNCs transplantation after MI. More importantly, these patients with missed opportunity for cell transplantation will still be able to achieve benefits from cell 
Density of vessels in cell injected zone
Capillary density within cell transplantation area in 24 hr, 7 day and 14 day group was more than that in M199 injection group (M199 group: 1.32/HPF; 24 hr, 7 day, 14 day group: 2.60 /HPF, 4.60/HPF, 3.80/HPF, respectively; all P-value Ͻ0.01). There was no significant difference between 1 hr treatment group and M199 group (P Ͼ 0.05, Fig. 5). Among all the injection groups, 7 day and 14 day groups had the highest capillary density. However, no difference was demonstrated between the two groups.
In vitro mimicry of the stiffness of infarcted myocardium
Identification of endothelial progenitor characteristics of BMMNCs under culture conditions of infarcted myocardium-like stiffness
On day 7 after culture, the percentage and number of doublepositive cells for FITC-UEA-1 binding and DiI-acLDL uptake had no significant differences among the infarcted myocardium-like stiffness under condition of 20 ng/ml VEGF (P Ͼ 0.05)
. In addition, the co-effects of infarcted myocardium-like stiffness and VEGF concentrations on inducing endothelial progenitor lineage specification of BMMNCs were demonstrated in the present research (P Ͻ 0.01). In two-way ANOVA, the stiffness of 42 kPa still
Fig. 1 Time-related changes in myocardial stiffness (A-F, right; G) and pathological staining (A-F, left) of the infarcted myocardium. (A) normal myocardium; (B) infarcted myocardum at hour 1; (C) infarcted myocardum at hour 24; (D) infarcted myocardum at day 7; (E) infarcted myocardum at day 14; (F) infarcted myocardum at day 28. Bars mean S.D. *P Ͻ 0.05 versus group A. showed the more benefits in terms of the percentage and number of FITC-UEA-1/DiI-AcLDL double-positive cells after controlling the impacts of VEGF concentrations
. Previous experimental studies have demonstrated that EPCs administration partially rescued cardiovascular dysfunction following myocardial injury with some evidence for EPCs contribution to new vessel growth
Fig. 3 The changes of cardiac function and left ventricular diameters after cell transplantation. (A1)-(D1) indicated the comparisons of cell transplantation (black column) and M199 transfer (grey column). (A2)-(D2) indicated the absolute changes of cardiac parameters from the control (M199 transfer
A1)-(D1) indicated the comparisons of cell transplantation (black column) and M199 transfer (grey column). (A2)-(D2) indicated the absolute changes of cardiac parameters from the control (M199 transfer
